Key result
Any use of tampons was associated with an increased risk of developing menses-associated toxic-shock syndrome compared with no use.
Why the study?
Does tampon use increase the risk of developing menses-associated toxic-shock syndrome in women?
Case-Control (n=240)
Yes
Does tampon use increase the risk of developing menses-associated toxic-shock syndrome in women?
Answers are grounded in this paper and cite their sources.
Tampon use, particularly brands with higher fluid capacity, is strongly associated with an increased risk of developing menses-associated toxic-shock syndrome.
Eighty women who had onset of toxic-shock syndrome (TSS) between October 1, 1979, and September 19, 1980, and 160 age- and sex-matched neighborhood controls participated in this study to evaluate risk factors associated with TSS in women. Of the 80 women, 76 had onset of illness during their menstrual periods. The odds ratio for developing menses-associated TSS with any use of tampons compared with no use of tampons was 18.01 (P less than 0.001). The odds ratios ranged from 5.29 to 27.5 for individual brand use compared with no use. When exclusive use of a particular tampon brand was compared with exclusive use of all other brands. Rely (Procter and Gamble, Cincinnati, Ohio) was the only brand with a significantly increased odds ratio (2.49; P = 0.005). By multiple logistic regression analysis, the risk of TSS was more closely associated with tampon fluid capacity (absorbency) than with the use of all tampon brands.
No takes yet. Share an insight, caveat, or question.
Osterholm et al. (1982) conducted a case-control in Toxic-shock syndrome (n=240). Tampon use vs. No use of tampons was evaluated on Menses-associated toxic-shock syndrome (OR 18.01, p=<0.001). Any use of tampons was associated with an increased risk of developing menses-associated toxic-shock syndrome compared with no use.
Synapse has enriched 10 related papers. Consider them for comparative context: